Publications:- 30+ International publications as first/corresponding author, few are listed below

1.  Kalra S, Bhattacharyya S, Bioequivalence study of two different dapagliflozin tablet formulations in healthy adult Indian volunteers. 2022 | Volume:  13 | Issue Number:  3 | Page: 235-241
2.  Bhattacharyya S. et al, Semaglutide Oral in Indian T2DM Patients (SOLID) Study Baseline Demographics, AACE poster 2022 (to be published in Endocrine Practice)
3.  Bhattacharyya S. et al, A Single Center Cross-sectional Study of Body Composition in Patients with Newly Diagnosed Type 2 Diabetes Mellitus, AACE poster 2022 (to be published in Endo Prac)
4.  Bhattacharyya S. EFFICACY AND SAFETY OF LIRAGLUTIDE IN AN INDIAN ADOLESCENT POPULATION WITH T2DM AND OBESITY: A SINGLE CENTRE EXPERIENCE FROM EASTERN INDIA, ATTD poster 2022
5.  Bhattacharyya S. Efficacy and Safety of Empagliflozin and Linagliptin Combination in Non-hospitalized COVID-19 Positive Patients with T2DM in Real World Setting: A Single Center Retrospective Study Endocrine Practice. 2021, ISSN: 1530-891X, Vol: 27, Issue: 6, Page: S57
6.  Bhattacharyya S. Efficacy and Safety of Once-Daily Fixed-Ratio Coformulation of Degludec-Aspart plus Empa-Lina 25/5 FDC in Post-Discharge COVID-19 Pneumonitis T2DM Patients Treated with Dexamethasone during Inpatient Stay, Diabetes Jun 2021, 70 (Supplement 1) 723-P; 
7.  Bhattacharyya S. Clinical Effectiveness of Dulaglutide Monotherapy in Obese Indian Adults with Prediabetes: First Report of A Real-World Retrospective Study in India. EndocrPract. 2019;25(Suppl 1):s104
8.  Bhattacharyya S. Safety and Efficacy of Faster Acting Insulin Aspart in People with Type 2 Diabetes and Chronic Kidney Disease: A Real-World Study from India. EndocrPract. 2020;26(Suppl 2):s101-2
9.  Bhattacharyya S. Real-World Clinical Effectiveness of Empagliflozin & Linagliptin Combination (Empa/Lina) in Indian T2D Subjects who are not willing to continue Insulin Therapy. EndocrPract. 2020;26(Suppl 2):s160
10. 1 Bhattacharyya S. Clinical effectiveness of combination therapy with dulaglutide, SGLT2 inhibitor and metformin with or without insulin in Indian adults with type 2 diabetes: a real-world retrospective study. Clinical Diabetology 2020; Jul 27. DOI: 10.5603/DK.2020.0026 [Epub ahead of print]
11.  Bhattacharyya S, Bhattacharyya S, Bhattacharyya K. Saroglitazar and its impact on Diabetic Dyslipidemia: A Real life Observational study from Eastern India. Indian Journal of Basic and Applied Medical Research. 2018; 7(2): 298-303.
12.  Bhattacharyya S, Bhattacharyya S. Safety and Efficacy of Insulin Degludec/Liraglutide Fixed-ratio Combination in Oad Failure Type 2 Diabetes Patients in a Tertiary Care Centre in Eastern India. Int J Diab 2020;7-9
     Bhattacharyya S, Khalse M. Clinical Effectiveness of Empagliflozin and Linagliptin Combination in Overweight or Obese T2DM Patients: Indian Real World Experience. Int J Diab 2020;14-18
13.  Bhattacharyya S, Bhattacharyya S, Bhattacharyya K. Evaluation of blood lipid parameters in type 2 diabetes mellitus subjects and its correlation with glycosylated hemoglobin: a prospective study from Eastern India. Indian Journal of Basic and Applied Medical Research. 2017; 6(2): 696-701.
14.  Bhattacharyya S, Mondal S, Pradhan R, Bhattacharyya D. Comparison of efficacy, compliance and incidence of hypoglycemia between conventional basal bolus and Oral hypoglycemic (OHA) regimen with a basal plus oral hypoglycemic regimen. International journal of Pharmaceutical Biological and Chemical Sciences. 2015; 4(4):16-19.
15.  Das AK, Mehndiratta C, Kalra S, Dhingra A, Tiwaskar M, Bhattacharyya S, et al. Medical nutrition therapy in diabetes management: A healthcare professional centric survey. Research & Reviews: Journal of Medical and Health Sciences. 2019;8 (Suppl Joint Event on Asia Pacific Conference on Diabetes & Oncology):s29
16.  Bhattacharyya S. Abstract B-04181: Adaptation of IDF-DAR guidance in real world practice: incidence of hypoglycaemia in patients observing ramadan fast. In: Proceedings of IDF Congress 2019, 2019 Dec 3-6; Busan. 2019. Available from: https://doi.org/10.26226/morressier.5d9b6234ea541d6ca8494051
    Book Chapters:- 5 book chapters including:
    1. Bhattacharyya S. Chap 47. Aligning Therapeutic Options with Management Goals in Elderly Patients with Diabetes. In: Saboo B, editors. RSSDI Diabetes Update 2019. New Delhi, Jaypee publishers; 2019. P214-218
    2.  Bhattacharyya S. Chap 47. DCCT & UKPDS. In: Saboo B, editors. RSSDI Diabetes Update 2020. New Delhi, Jaypee publishers; 2020.

1.  ‘Inspiring Endocrinologist & Diabetologist of India Award 2022’ –Economic Times (Doctor’s Day Conclave’ New Delhi 2022)
2.  ‘International Rising Star Award 2021’- International Diabetes Center, Park Nicollet
3.  ‘Rising star Award 2021’ (Endocrinology &Diabetes)- Indian Academy of Diabetes
4.  RSSDI 2020 award for ‘Best innovation in Diabetes Care during challenging times’
5.  ‘Best Oral Paper presentation’ – ASIA Pacific Congress of Hypertension 2021
6.  ‘ACP Governor’s Recognition Award 2021’, for exceptional contribution as Scientific Secretary ACP India Annual Conference 2022
7.  Best National Diabetes Awareness Initiative Award 2016, by DIABETES INDIA at 7 th World Congress of Diabetes, Feb 2017
8.  National Scholar & Rank holder in 10 th Board exam & Gold certificate holder in A-level exam (UK)
9.  Distinction holder in Medical school & Post Graduation